Cost-effective analysis of atorvastatin based on outcome data from a large cohort undergoing PCI before and after the availability of atorvastatin for patients with social health insurance

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Public Health and Health Economics ePosters Health Policy ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by